Status:
COMPLETED
Quality Control of CE-Certified Phonak Hearing Aids - 2017_37
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss, Sensorineural
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated ma...
Eligibility Criteria
Inclusion
- Adult hearing impaired persons (minimum age: 18 years) with at least 3 months experience with hearing aids
- Good written and spoken (Swiss) German language skills
- Healthy outer ear
- Ability to fill in a questionnaire (p/eCRF) conscientiously
- Informed Consent as documented by signature
Exclusion
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Massively limited dexterity
- Known psychological problems
- Central hearing disorders
Key Trial Info
Start Date :
January 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03379766
Start Date
January 8 2018
End Date
February 2 2018
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova AG
Stäfa, Canton of Zurich, Switzerland, 8712